---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-26-000041"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2026-10-01T10:52:00+00:00"
generated_at: "2026-10-12T14:13:55.422443+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health extends CVS distribution pact to June 2032; reaffirms FY2027 EPS guidance of $12.40-$12.60

## Summary
- Binding letter of intent extends Cardinal Health's existing pharmaceutical distribution agreement with CVS Health through June 30, 2032, continuing the current scope of distribution services.
- FY2027 non-GAAP EPS guidance reaffirmed at $12.40 to $12.60, which the company said equals 13% to 15% growth.
- Long-term non-GAAP EPS growth guidance of 12% to 14% reiterated alongside the renewal.
- CEO Jason Hollar cited the 'long-standing partnership with CVS Health'; further updates may come on the Q1 earnings call scheduled for November 5, 2026.

## SEC filing metadata
- accession: 0000721371-26-000041
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2026-10-01T10:52:00+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137126000041/0000721371-26-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137126000041/cah-20261001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-26-000041
- JSON: https://secwatch.observer/filing/0000721371-26-000041.json
- Plain text: https://secwatch.observer/filing/0000721371-26-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.